Implementation of hepatitis C cure in Australia: one year on
Objectives: Direct-acting antivirals (DAAs) for the treatment of hepatitis C (HCV) became universally available in Australia in March 2016, with an aim to achieve HCV elimination. Fourteen per cent of Australians with HCV have initiated treatment. The objective of this study was to explore and ident...
Saved in:
Main Authors: | Jacqueline A. Richmond (Author), Jack Wallace (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective
by: Jack Wallace, et al.
Published: (2013) -
Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
by: Annie Madden, et al.
Published: (2018) -
A CURE FOR RECENTLY ACQUIRED HEPATITIS C
by: Radka Komitova, et al.
Published: (2022) -
The emergence of NASH issues after cure of hepatitis C
by: Lawrence Serfaty
Published: (2018) -
Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia
by: Jack Wallace, et al.
Published: (2022)